z6com尊龙凯时官网

Uni-Bio Science (00690.HK)'s Uni-GLP Injection Clinical Trial Application Accepted by National Medical Products Administration

Uni-Bio Science (00690.HK)'s Uni-GLP Injection Clinical Trial Application Accepted by National Medical Products Administration

Uni-Bio Science (00690.HK)'s Uni-GLP Injection Clinical Trial Application Accepted by National Medical Products Administration

2020-07-15

View details

Uni-Bio Science Group and Medlink Builds Strategic Partnership,Expansion of Value Chain towards Pharmaceutical E-commerce

Uni-Bio Science Group and Medlink Builds Strategic Partnership,Expansion of Value Chain towards Pharmaceutical E-commerce

2020-05-14

View details

Collaboration between Uni-Bio Science Group and Swiss company Ypsomed to jointly develop 2nd generation diabetes and osteoporosis products

Collaboration between Uni-Bio Science Group and Swiss company Ypsomed to jointly develop 2nd generation diabetes and osteoporosis products

2020-05-05

View details

Uni-Bio Science Group, Sinopharm Weiqida Pharmaceutical and Suzhou Yingli Medical Technology Build Strategic Partnership on Acarbose Industry Value Chain

Uni-Bio Science Group, Sinopharm Weiqida Pharmaceutical and Suzhou Yingli Medical Technology Build Strategic Partnership on Acarbose Industry Value Chain

2020-04-15

View details

2019 Annual Results Turnover Increased by 54.9% YoY to HK$209.4 million Recording EBITDA of HK$28.4 million Achieved Significant Progress towards Pipeline Product with 2 Product Launches Expected in 2020

2019 Annual Results Turnover Increased by 54.9% YoY to HK$209.4 million Recording EBITDA of HK$28.4 million Achieved Significant Progress towards Pipeline Product with 2 Product Launches Expected in 2020

2020-04-01

View details

1...
<<
4
5
6
7
8
>>
16

Hot news

<form id='8pggJ'></form>

<bdo id='0brkC'><sup id='UFs6B'><div id='0fK4w'><bdo id='VBOY0'></bdo></div></sup></bdo>